Cargando…
Erythrocytic α-synuclein contained in microvesicles regulates astrocytic glutamate homeostasis: a new perspective on Parkinson’s disease pathogenesis
Parkinson’s disease is a neurodegenerative disorder characterized by the transmission and accumulation of toxic species of α-synuclein (α-syn). Extracellular vesicles (EVs) are believed to play a vital role in the spread of toxic α-syn species. Recently, peripheral α-syn pathology has been investiga...
Autores principales: | Sheng, Lifu, Stewart, Tessandra, Yang, Dishun, Thorland, Eric, Soltys, David, Aro, Patrick, Khrisat, Tarek, Xie, Zhiying, Li, Na, Liu, Zongran, Tian, Chen, Bercow, Matthew, Matsumoto, Junichi, Zabetian, Cyrus P., Peskind, Elaine, Quinn, Joseph F., Shi, Min, Zhang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7346449/ https://www.ncbi.nlm.nih.gov/pubmed/32641150 http://dx.doi.org/10.1186/s40478-020-00983-w |
Ejemplares similares
-
Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
por: Tian, Chen, et al.
Publicado: (2019) -
Reduced erythrocytic CHCHD2 mRNA is associated with brain pathology of Parkinson’s disease
por: Liu, Xiaodan, et al.
Publicado: (2021) -
Transmission of α-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: another mechanism for initiation and progression of Parkinson’s disease?
por: Matsumoto, Junichi, et al.
Publicado: (2017) -
Targeted Discovery and Validation
of Plasma Biomarkers
of Parkinson’s Disease
por: Pan, Catherine, et al.
Publicado: (2014) -
α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson’s disease
por: Liu, Zongran, et al.
Publicado: (2022)